|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||
| Prepaid Expenses | ||||||||||
| Total Current Assets | ||||||||||
| Intangible Assets, Net | ||||||||||
| Total Assets | ||||||||||
| Accounts Payable | ||||||||||
| Accounts Payable – Related Party | ||||||||||
| Deferred Revenue | ||||||||||
| Total Current Liabilities | ||||||||||
| Common stock, $0.0001 par value, 75,000,000 shares authorized; 3,803,370 and 3,803,370 shares issued and outstanding as of April 30, 2026 and July 31, 2025, respectively | ||||||||||
| Additional Paid in Capital | ||||||||||
| Accumulated Deficit | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
